Melanny Ika Sulistyowaty, - and Galih Satrio Putra, - and Tutuk Budiati, - and Katsuyoshi Matsunami, - (2020) Synthesis, In Vitro Anticancer Activity and In Silico Study of some Benzylidene Hydrazide Derivatives. Key Engineering Materials, 840. pp. 277-283. ISSN 1662-9795
Text (FULLTEXT)
C-03 Artikel.pdf Download (1MB) |
|
Text (PEER REVIEW)
c3.pdf Download (1MB) |
|
Text (SIMILARITY)
C-03 Similarity.pdf Download (1MB) |
|
Text (KORESPONDENSI)
BUKTI KOREFPONDENSI C3.pdf Download (587kB) |
Abstract
Some benzylidenehydrazides (3a-e) have been synthesized in three reaction steps from anthranilic acid in good yields, about 70% - 99%. The structures of the synthesized compounds were analyzed using spectroscopic methods. The compounds were evaluated its activity against human lung cancer, A549 cell line by MTT method and studied its molecular docking onto the protein tyrosine kinase (PDB ID: 1M17) by using Molegro® vs. 5.5. The data showed that N-(2-(2-(4-nitrobenzylidene)hydrazinecarbonyl)phenyl)benzamide (3d) which synthesized in 70% yield and has the highest activity on inhibiting the growth of A549 cell line with IC50 10.9μg/mL, which was linier with our in silico study. Compound 3d has the smallest RS value -94.44 kcal/mol, lower than selected Ligand, Erlotinib.
Item Type: | Article | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Uncontrolled Keywords: | Synthesis, benzylidene hydrazides, A549 cell line, docking study, tyrosine kinase | ||||||||||
Subjects: | R Medicine R Medicine > RS Pharmacy and materia medica R Medicine > RS Pharmacy and materia medica > RS1-441 Pharmacy and materia medica R Medicine > RS Pharmacy and materia medica > RS200-201 Pharmaceutical dosage forms |
||||||||||
Creators: |
|
||||||||||
Depositing User: | Mr M. Fuad Sofyan | ||||||||||
Date Deposited: | 21 Sep 2021 05:38 | ||||||||||
Last Modified: | 21 Dec 2021 05:37 | ||||||||||
URI: | http://repository.unair.ac.id/id/eprint/109972 | ||||||||||
Sosial Share: | |||||||||||
Actions (login required)
View Item |